These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14678018)

  • 1. Elevated number of cells secreting transforming growth factor beta in Guillain-Barré syndrome.
    Dahle C; Kvarnstrom M; Ekerfelt C; Samuelsson M; Ernerudh J
    APMIS; 2003 Dec; 111(12):1095-104. PubMed ID: 14678018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group.
    Press R; Deretzi G; Zou LP; Zhu J; Fredman P; Lycke J; Link H
    J Neuroimmunol; 2001 Jan; 112(1-2):129-38. PubMed ID: 11108941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-T(H)1 cytokines are augmented systematically early in Guillain-Barré syndrome.
    Press R; Ozenci V; Kouwenhoven M; Link H
    Neurology; 2002 Feb; 58(3):476-8. PubMed ID: 11839856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of TNFalpha and TGFbeta1 in Guillain-Barré syndrome: correlation of a low TNFalpha-/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment.
    Ossege LM; Sindern E; Voss B; Malin JP
    Eur J Neurol; 2000 Jan; 7(1):17-25. PubMed ID: 10809911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis.
    Link J; He B; Navikas V; Palasik W; Fredrikson S; Söderström M; Link H
    J Neuroimmunol; 1995 Apr; 58(1):21-35. PubMed ID: 7537278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
    Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of miR155 promotes the production of inflammatory mediators in Guillain-Barré syndrome in vitro.
    Wang YZ; Feng XG; Shi QG; Hao YL; Yang Y; Zhang AM; Kong QX
    Inflammation; 2013 Apr; 36(2):337-45. PubMed ID: 23065188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barré syndrome.
    Liang SL; Wang WZ; Huang S; Wang XK; Zhang S; Wu Y
    Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):1039-46. PubMed ID: 22738814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine secretion in decidual mononuclear cells from term human pregnancy with or without labour: ELISPOT detection of IFN-gamma, IL-4, IL-10, TGF-beta and TNF-alpha.
    Gustafsson C; Hummerdal P; Matthiesen L; Berg G; Ekerfelt C; Ernerudh J
    J Reprod Immunol; 2006 Aug; 71(1):41-56. PubMed ID: 16730071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to myelin proteins in Guillain-Barré syndrome.
    Makowska A; Pritchard J; Sanvito L; Gregson N; Peakman M; Hayday A; Hughes R
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):664-71. PubMed ID: 17717020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement.
    Dlugovitzky D; Bay ML; Rateni L; Urízar L; Rondelli CF; Largacha C; Farroni MA; Molteni O; Bottasso OA
    Scand J Immunol; 1999 Feb; 49(2):210-7. PubMed ID: 10075027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA.
    Horwitz DA; Wang H; Gray JD
    Lupus; 1994 Oct; 3(5):423-8. PubMed ID: 7841998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome.
    Nyati KK; Prasad KN; Rizwan A; Verma A; Paliwal VK
    Arch Neurol; 2011 Apr; 68(4):445-52. PubMed ID: 21482924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barré syndrome.
    Li C; Zhao P; Sun X; Che Y; Jiang Y
    Mediators Inflamm; 2013; 2013():639712. PubMed ID: 24174711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis.
    Link J; Navikas V; Yu M; Fredrikson S; Osterman PO; Link H
    J Neuroimmunol; 1994 May; 51(2):185-92. PubMed ID: 8182116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-35 Is Involved in the Pathogenesis of Guillain-Barré Syndrome Through Its Influence on the Function of CD4+ T Cells.
    Liu H; Zhang W; Tian FF; Kun A; Zhou WB; Xiao B; Li J
    Immunol Invest; 2015; 44(6):566-77. PubMed ID: 26225474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
    Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
    Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 2 and -4 are involved in the pathogenesis of the Guillain-Barré syndrome.
    Du Y; Zhang G; Zhang Z; Wang Q; Ma R; Zhang L; Fan F; Li Y; Wang M; Lv H; Kang X
    Mol Med Rep; 2015 Aug; 12(2):3207-13. PubMed ID: 25954926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.